Pinealon is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Pinealon is being researched for anxiety applications. Activates gene expression and protein synthesis in neural tissues while reducing apoptosis. Displays neuroprotection through reduced oxidative stress, enhanced cerebellum neuron resistance, and improv. Common dosages for this use range from 10-30 mcg daily once daily.
Can Pinealon Help With Anxiety?
Pinealon (Glu-Asp-Arg tripeptide (EDR)) is being researched for anxiety applications based on its mechanism as a Tripeptide geroprotector, neuropeptide.
Activates gene expression and protein synthesis in neural tissues while reducing apoptosis. Displays neuroprotection through reduced oxidative stress, enhanced cerebellum neuron resistance, and improved mitochondrial function in aging brains.
What Does the Research Show for Pinealon and Anxiety?
Russian research in 72+ patient cohorts demonstrates cognitive improvements after traumatic brain injury and age-related decline. Enhanced memory and emotional stability documented. Limited English-language literature.
The relevance to anxiety specifically comes from Pinealon's effects on cognitive function improvement, neuroprotection, enhanced cerebellum protection, reduced brain cell apoptosis, emotional balance.
What Protocol Is Used for Anxiety?
For anxiety applications, the standard Pinealon protocol is 10-30 mcg daily administered once daily via subcutaneous injection for 5-10 day cycles, repeated with rest periods.
Some researchers adjust dosing based on the specific anxiety application — see our Pinealon dosage guide for full protocol details.
Can Stacking Improve Anxiety Results?
Complements Epithalon (telomere) and Cerebrolysin (neurotrophic factors) for comprehensive brain aging intervention.
What Side Effects Apply to Anxiety Use?
Generally well-tolerated. Potential injection site reactions, mild muscle aches, headache, transient lightheadedness.
Side effects are generally consistent regardless of the specific application. See our Pinealon side effects guide for details.
Calculate Your Pinealon Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Pinealon.
Open Calculator →Bottom Line: Pinealon for Anxiety
Pinealon shows preliminary research potential for anxiety. Standard protocols (10-30 mcg daily, once daily, 5-10 day cycles, repeated with rest periods) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
Pinealon : Benefits, Dosage, Side Effects & Research
Related Reading
- Pinealon Dosage Guide
- Pinealon Benefits
- Pinealon Side Effects
- Pinealon Stacking Guide
- Pinealon Cycle Guide
- Pinealon Research
Research-Grade Sourcing
If you're going to research Pinealon, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Pinealon?
Pinealon (Glu-Asp-Arg tripeptide (EDR)) is a Tripeptide geroprotector, neuropeptide. Synthetic tripeptide derived from pineal gland secretions; Russian-developed geroprotector. It is researched for cognitive function improvement, neuroprotection, enhanced cerebellum protection, reduced brain cell apoptosis, emotional balance.
What is the recommended Pinealon dosage?
Common dosages: 10-30 mcg daily administered once daily via subcutaneous injection. Cycle length: 5-10 day cycles, repeated with rest periods. Half-life: estimated 18-24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of Pinealon?
Generally well-tolerated. Potential injection site reactions, mild muscle aches, headache, transient lightheadedness.
Is Pinealon safe?
Pinealon has shown a favorable safety profile in research. Not FDA-approved. Used clinically in Russia. Research-only in US. All research should follow appropriate safety protocols.